<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen H</submitter><funding>Hong Kong General Research Fund</funding><funding>Tong-ren-tang Pharmaceutical Inc. LTD</funding><funding>Shenzhen Basic Research Plan Project</funding><pagination>51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9044615</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Hemorrhagic transformation (HT) is a common complication of delayed tissue plasminogen activator (t-PA) treatment for ischemic stroke. Peroxynitrite plays an important role in the breakdown of blood-brain barrier (BBB) and the development of HT. We tested the hypothesis that Angong Niuhuang Wan (AGNHW), a traditional Chinese medicinal formula, could be used in conjunction with t-PA to protect the BBB, minimize HT, and improve neurological function by suppressing peroxynitrite-mediated matrix metalloproteinase-9 (MMP-9) activation.&lt;h4>Methods&lt;/h4>We first performed quality control study and chemical identification of AGNHW by using UPLC. In animal experiments, male Sprague-Dawley rats were subjected to 5 h of middle cerebral artery occlusion (MCAO) followed by 19 h of rep</pubmed_abstract><journal>Chinese medicine</journal><pubmed_title>Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation.</pubmed_title><pmcid>PMC9044615</pmcid><funding_grant_id>SIRI/04/04/2015/06</funding_grant_id><funding_grant_id>17118717</funding_grant_id><funding_grant_id>AoE/P-705/16 Areas of Excellence Scheme</funding_grant_id><funding_grant_id>17105220</funding_grant_id><pubmed_authors>Gu B</pubmed_authors><pubmed_authors>Shen J</pubmed_authors><pubmed_authors>Tsoi B</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Chen H</pubmed_authors><pubmed_authors>Qi S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation.</name><description>&lt;h4>Background&lt;/h4>Hemorrhagic transformation (HT) is a common complication of delayed tissue plasminogen activator (t-PA) treatment for ischemic stroke. Peroxynitrite plays an important role in the breakdown of blood-brain barrier (BBB) and the development of HT. We tested the hypothesis that Angong Niuhuang Wan (AGNHW), a traditional Chinese medicinal formula, could be used in conjunction with t-PA to protect the BBB, minimize HT, and improve neurological function by suppressing peroxynitrite-mediated matrix metalloproteinase-9 (MMP-9) activation.&lt;h4>Methods&lt;/h4>We first performed quality control study and chemical identification of AGNHW by using UPLC. In animal experiments, male Sprague-Dawley rats were subjected to 5 h of middle cerebral artery occlusion (MCAO) followed by 19 h of rep</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-05T11:59:40.82Z</modification><creation>2025-04-05T11:59:40.82Z</creation></dates><accession>S-EPMC9044615</accession><cross_references><pubmed>35477576</pubmed><doi>10.1186/s13020-022-00595-7</doi></cross_references></HashMap>